Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice - ScienceDirect
Biomedicines | Free Full-Text | Targeting CDK4/6 for Anticancer Therapy
Dr. Prenek Lilla
Treating cancer with selective CDK4/6 inhibitors | Nature Reviews Clinical Oncology
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19 | SpringerLink
Potential combination strategies for CDK4/6 inhibitors. CDK4/6... | Download Scientific Diagram
PROactively TACkling CDK4/6 therapy resistance | Nature Cancer
Inhibition of G1/S cyclin-dependent kinases by CDK4/6 inhibitors. A The... | Download Scientific Diagram
CD40 agonist-induced IL-12p40 potentiates hepatotoxicity | Journal for ImmunoTherapy of Cancer
Intrinsic and acquired resistance to CDK4/6 inhibitors and potential overcoming strategies | Acta Pharmacologica Sinica
Small molecule CDK4/6 inhibitors inhibit cell cycle progression by... | Download Scientific Diagram
Immunomodulation by anticancer cell cycle inhibitors | Nature Reviews Immunology
Mechanisms of therapeutic CDK4/6 inhibition in breast cancer - ScienceDirect
The Use of Post-attachment Inhibitors for HIV Treatment
Uptake és efflux transzporterekkel kölcsönható vegyületek azonosítása robotizált platformon
Co-inhibitory signals. (A) CTLA-4 signal may inhibit T cells through... | Download Scientific Diagram
A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding | PNAS
Mechanism of action of CTLA-4 checkpoint inhibitor. CTLA-4 and CD28 are... | Download Scientific Diagram
The Use of Post-attachment Inhibitors for HIV Treatment
